KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Amortization of Goodwill (2024)

Historic Amortization of Goodwill for Pacira BioSciences (PCRX) over the last 1 years, with Q3 2024 value amounting to $163.2 million.

  • Pacira BioSciences' Amortization of Goodwill changed N/A to $163.2 million in Q3 2024 from the same period last year, while for Sep 2025 it was $163.2 million, marking a year-over-year change of. This contributed to the annual value of $163.2 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Pacira BioSciences reported Amortization of Goodwill of $163.2 million as of Q3 2024.
  • In the past 5 years, Pacira BioSciences' Amortization of Goodwill ranged from a high of $163.2 million in Q3 2024 and a low of $163.2 million during Q3 2024